| abstract |
The technical problem to be solved by the present invention is to provide a pharmaceutical composition for preventing or treating cancer of the urinary organ, which has no side effects, can be used for a long time and can be continuously used, and is administered to the urinary organ by injecting it into the cavity of the urinary organ. The present invention is constituted as follows: a solution for intraluminal injection of the urinary organ, which contains D-allose; the intraluminal urinary tract is the upper urinary tract and the bladder; the intraluminal injection of the urinary organ is a solution for therapy; A solution for enhancing the uptake of sugar into cancer cells of urinary organs (eg RT112, 253J, J82); a solution containing D-allose together with a pharmaceutically acceptable diluent or carrier; used for prophylaxis or treatment of urinary organs The pharmaceutical composition of organ cancer. |